Epidemiology of Alzheimer’s disease and dementia

Atlas of Alzheimer’s Disease

Volumn , Issue , 2007, Pages 27-40

  Hsiung, Ging Yuek Robin ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80054826639     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.3109/9781435626133-2     Document Type: Chapter

References (83)

1. Rothman K, Greenland S. Modern Epidemiology. Philadelphia: Lippincott-Raven, 1998.
2. Kukull WA, Ganguli M. Epidemiology of dementia:concepts and overview. Neurol Clin 2000; 18: 923-50.
3. CSHA. Canadian study of health and aging: study methods and prevalence of dementia. CMAJ 1994; 150: 899-913.
4. Hendrie HC. Epidemiology of dementia and Alzheimer’s disease. Am J Geriatr Psychiatry 1998; 6: S3-18.
5. Ferri CP, Prince M, Brayne C et al. Global prevalence of dementia: a Delphi consensus study. Lancet 2005; 366:2112-17.
6. Fitzpatrick AL, Kuller LH, Ives DG et al. Incidence and prevalence of dementia in the Cardiovascular Health Study. J Am Geriatr Soc 2004; 52: 195-204.
7. Fratiglioni L, De Ronchi D, Aguero-Torres H. Worldwide prevalence and incidence of dementia. Drugs Aging 1999; 15: 365-75.
8. Hamad AI, Ibrahim MA, Sulaiti EM. Dementia in Qatar. Saudi Med J 2004; 25: 79-82.
9. Jellinger K. Prevalence of Alzheimer’s disease in very elderly people: a prospective neuropathological study. Neurology 2002; 58: 671-2; author reply 671-2.
10. Lin RT, Lai CL, Tai CT et al. Prevalence and subtypes of dementia in southern Taiwan: impact of age, sex, education, and urbanization. J Neurol Sci 1998; 160: 67-75.
11. Liu CK, Lin RT, Chen YF et al. Prevalence of dementia in an urban area in Taiwan. J Formos Med Assoc 1996; 95: 7628.
12. Liu HC, Fuh JL, Wang SJ et al. Prevalence and subtypes of dementia in a rural Chinese population. Alzheimer Dis Assoc Disord 1998; 12: 127-34.
13. Lobo A, Launer LJ, Fratiglioni L et al. Prevalence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 2000; 54: S4-9.
14. Rice DP, Fillit HM, Max W et al. Prevalence, costs, and treatment of Alzheimer’s disease and related dementia: a managed care perspective. Am J Manag Care 2001; 7:809-18.
15. Ogura C, Nakamoto H, Uema T et al. Prevalence of senile dementia in Okinawa, Japan. COSEPO Group. Study Group of Epidemiology for Psychiatry in Okinawa. Int J Epidemiol 1995; 24: 373-80.
16. Sayetta RB. Rates of senile dementia, Alzheimer’s type, in the Baltimore Longitudinal Study. J Chronic Dis 1986; 39: 271-86.
17. Shiba M, Shimogaito J, Kose A et al. Prevalence of dementia in the rural village of Hanazono-mura, Japan. Neuroepidemiology 1999; 18: 32-6.
18. Ueda K, Kawano H, Hasuo Y, Fujishima M. Prevalence and etiology of dementia in a Japanese community. Stroke 1992; 23: 798-803.
19. Zhang MY, Katzman R, Salmon D et al. The prevalence of dementia and Alzheimer’s disease in Shanghai, China:impact of age, gender, and education. Ann Neurol 1990; 27: 428-37.
20. Yamada T, Kadekaru H, Matsumoto S et al. Prevalence of dementia in the older Japanese-Brazilian population. Psychiatry Clin Neurosci 2002; 56: 71-5.
21. Woo JI, Lee JH, Yoo KY et al. Prevalence estimation of dementia in a rural area of Korea. J Am Geriatr Soc 1998; 46: 983-7.
22. Henderson S. Epidemiology of dementia. Ann Med Interne (Paris) 1998; 149: 181-6.
23. Feldman H, Levy AR, Hsiung GY et al. A Canadian cohort study of cognitive impairment and related dementias (ACCORD): study methods and baseline results. Neuroepidemiology 2003; 22: 265-74.
24. McMurtray A, Clark DG, Christine D, Mendez MF. Early-onset dementia: frequency and causes compared to late-onset dementia. Dement Geriatr Cogn Disord 2006; 21: 59-64.
25. Barker WW, Luis CA, Kashuba A et al. Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the State of Florida Brain Bank. Alzheimer Dis Assoc Disord 2002; 16: 203-12.
26. White L, Petrovitch H, Ross GW et al. Prevalence of dementia in older Japanese-American men in Hawaii: The Honolulu-Asia Aging Study. JAMA 1996; 276: 955-60.
27. Hasegawa K. The clinical issues of age-related dementia. Tohoku J Exp Med 1990; 161(Suppl): 29-38.
28. Kuang PG. [A survey on senile mental disturbances in Wuhan City in 1981.] Zhonghua Liu Xing Bing Xue Za Zhi 1984; 5: 95-9.
29. Li G, Shen YC, Chen CH et al. An epidemiological survey of age-related dementia in an urban area of Beijing. Acta Psychiatr Scand 1989; 79: 557-63.
30. Yamada M, Sasaki H, Mimori Y et al. Prevalence and risks of dementia in the Japanese population: RERF’s adult health study Hiroshima subjects. Radiation Effects Research Foundation. J Am Geriatr Soc 1999; 47: 189-95.
31. Park J, Ko HJ, Park YN, Jung CH. Dementia among the elderly in a rural Korean community. Br J Psychiatry 1994; 164: 796-801.
32. Suh GH, Shah A. A review of the epidemiological transition in dementia-cross-national comparisons of the indices related to Alzheimer’s disease and vascular dementia. Acta Psychiatr Scand 2001; 104: 4-11.
33. Hagnell O, Lanke J, Rorsman B, Ojesjo L. Does the incidence of age psychosis decrease? A prospective, longitudinal study of a complete population investigated during the 25-year period 1947-1972: the Lundby study. Neuropsychobiology 1981; 7: 201-11.
34. Bickel H, Cooper B. Incidence and relative risk of dementia in an urban elderly population: findings of a prospective field study. Psychol Med 1994; 24: 179-92.
35. Boothby H, Blizard R, Livingston G, Mann AH. The Gospel Oak Study stage III: the incidence of dementia. Psychol Med 1994; 24: 89-95.
36. Letenneur L, Commenges D, Dartigues JF, Barberger-Gateau P. Incidence of dementia and Alzheimer’s disease in elderly community residents of south-western France. Int J Epidemiol 1994; 23: 1256-61.
37. Fratiglioni L, Viitanen M, von Strauss E et al. Very old women at highest risk of dementia and Alzheimer’s disease: incidence data from the Kungsholmen Project, Stockholm. Neurology 1997; 48: 132-8.
38. Liu CK, Lai CL, Tai CT et al. Incidence and subtypes of dementia in southern Taiwan: impact of socio-demographic factors. Neurology 1998; 50: 1572-9.
39. CSHA. The incidence of dementia in Canada. The Canadian Study of Health and Aging Working Group. Neurology 2000; 55: 66-73.
40. Nitrini R, Caramelli P, Herrera E Jr et al. Incidence of dementia in a community-dwelling Brazilian population. Alzheimer Dis Assoc Disord 2004; 18: 24-16.
41. Yoshitake T, Kiyohara Y, Kato I et al. Incidence and risk factors of vascular dementia and Alzheimer’s disease in a defined elderly Japanese population: the Hisayama Study. Neurology 1995; 45: 1161-8.
42. Hebert LE, Scherr PA, Beckett LA et al. Age-specific incidence of Alzheimer’s disease in a community population. JAMA 1995; 273: 1354-9.
43. Payami H, Grimslid H, Oken B et al. A prospective study of cognitive health in the elderly (Oregon Brain Aging Study): effects of family history and apolipoprotein E genotype. Am J Hum Genet 1997; 60: 948-56.
44. Gonzales McNeal M, Zareparsi S, Camicioli R et al. Predictors of healthy brain aging. J Gerontol A Biol Sci Med Sci 2001; 56: B294-301.
45. Johansson B, Hofer SM, Allaire JC et al. Change in cognitive capabilities in the oldest old: the effects of proximity to death in genetically related individuals over a 6-year period. Psychol Aging 2004; 19: 145-56.
46. Lautenschlager NT, Cupples LA, Rao VS et al. Risk of dementia among relatives of Alzheimer’s disease patients in the MIRAGE study: what is in store for the oldest old? Neurology 1996; 46: 641-50.
47. Walsh JS, Welch HG, Larson EB. Survival of outpatients with Alzheimer-type dementia. Ann Intern Med 1990; 113: 429-34.
48. Wolfson C, Wolfson DB, Asgharian M et al. A reevaluation of the duration of survival after the onset of dementia. N Engl J Med 2001; 344: 1111-16.
49. Brookmeyer R, Corrada MM, Curriero FC, Kawas C. Survival following a diagnosis of Alzheimer disease. Arch Neurol 2002; 59: 1764-7.
50. Hui JS, Wilson RS, Bennett DA et al. Rate of cognitive decline and mortality in Alzheimer’s disease. Neurology 2003; 61: 1356-61.
51. Brookmeyer R, Gray S, Kawas C. Projections of Alzheimer’s disease in the United States and the public health impact of delaying disease onset. Am J Public Health 1998; 88: 1337-42.
52. Ott A, Breteler MM, van Harskamp F, Stijnen T, Hofman A. Incidence and risk of dementia. The Rotterdam Study. Am J Epidemiol 1998; 147: 574-80.
53. Fratiglioni L, Launer LJ, Andersen K et al. Incidence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 2000; 54: S10-15.
54. Andersen K, Launer LJ, Dewey ME et al. Gender differences in the incidence of AD and vascular dementia: The EURODEM Studies. EURODEM Incidence Research Group. Neurology 1999; 53: 1992-7.
55. Kawas C, Gray S, Brookmeyer R, Fozard J, Zonderman A. Age-specific incidence rates of Alzheimer’s disease: the Baltimore Longitudinal Study of Aging. Neurology 2000; 54: 2072-7.
56. Shadlen MF, Larson EB, Yukawa M. The epidemiology of Alzheimer’s disease and vascular dementia in Japanese and African-American populations: the search for etiological clues. Neurobiol Aging 2000; 21: 171-81.
57. McDowell I. Alzheimer’s disease: insights from epidemiology. Aging (Milano) 2001; 13: 143-62.
58. Nussbaum RL, Ellis CE. Alzheimer’s disease and Parkinson’s disease. N Engl J Med 2003; 348: 1356-64.
59. Evans DA, Hebert LE, Beckett LA et al. Education and other measures of socioeconomic status and risk of incident Alzheimer disease in a defined population of older persons. Arch Neurol 1997; 54: 1399-405.
60. Stern Y, Gurland B, Tatemichi TK et al. Influence of education and occupation on the incidence of Alzheimer’s disease. JAMA 1994; 271: 1004-10.
61. Katzman R. Education and the prevalence of dementia and Alzheimer’s disease. Neurology 1993; 43: 13-20.
62. Lindsay J, Laurin D, Verreault R et al. Risk factors for Alzheimer’s disease: a prospective analysis from the Canadian Study of Health and Aging. Am J Epidemiol 2002; 156: 445-53.
63. Hsiung GY, Sadovnick AD, Feldman H. Apolipoprotein E epsilon4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging. CMAJ 2004; 171: 863-7.
64. Snowdon DA, Kemper SJ, Mortimer JA et al. Linguistic ability in early life and cognitive function and Alzheimer’s disease in late life. Findings from the Nun Study. JAMA 1996; 275: 528-32.
65. Whalley LJ, Starr JM, Athawes R et al. Childhood mental ability and dementia. Neurology 2000; 55: 1455-9.
66. Kukull WA, Bowen JD. Dementia epidemiology. Med Clin North Am 2002; 86: 573-90.
67. Scarmeas N, Stern Y. Cognitive reserve and lifestyle. J Clin Exp Neuropsychol 2003; 25: 625-33.
68. van Duijn CM, Clayton D, Chandra V et al. Familial aggregation of Alzheimer’s disease and related disorders: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. Int J Epidemiol 1991; 20 (Suppl 2): S13-20.
69. Green RC, Cupples LA, Go R et al. Risk of dementia among white and African American relatives of patients with Alzheimer disease. JAMA 2002; 287: 329-36.
70. Bird TD. Genetic factors in Alzheimer’s disease. N Engl J Med 2005; 352: 862-4.
71. Shobab LA, Hsiung GY, Feldman HH. Cholesterol in Alzheimer’s disease. Lancet Neurol 2005; 4: 841-52.
72. Farrer LA, Cupples LA, Haines JL et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 1997; 278: 1349-56.
73. Smith GE, Bohac DL, Waring SC et al. Apolipoprotein E genotype influences cognitive ‘phenotype’ in patients with Alzheimer’s disease but not in healthy control subjects. Neurology 1998; 50: 355-62.
74. Ashford JW, Mortimer JA. Non-familial Alzheimer’s disease is mainly due to genetic factors. J Alzheimers Dis 2002; 4: 169-77.
75. Warwick Daw E, Payami H, Nemens EJ et al. The number of trait loci in late-onset Alzheimer disease. Am J Hum Genet 2000; 66: 196-204.
76. Tol J, Roks G, Slooter AJ, van Duijn CM. Genetic and environmental factors in Alzheimer’s disease. Rev Neurol (Paris) 1999; 155(Suppl 4): S10-16.
77. Raber J, Huang Y, Ashford JW. ApoE genotype accounts for the vast majority of AD risk and AD pathology. Neurobiol Aging 2004; 25: 641-50.
78. Blacker D, Haines JL, Rodes L et al. ApoE-4 and age at onset of Alzheimer’s disease: the NIMH genetics initiative. Neurology 1997; 48: 139-47.
79. Wijsman EM, Daw EW, Yu CE et al. Evidence for a novel late-onset Alzheimer disease locus on chromosome 19p13.2. Am J Hum Genet 2004; 75: 398-409.
80. Liang X, Schnetz-Boutaud N, Kenealy SJ et al. Covariate analysis of late-onset Alzheimer disease refines the chromosome 12 locus. Mol Psychiatry 2006; 11: 280-5.
81. Ertekin-Taner N, Ronald J, Asahara H et al. Fine mapping of the alpha-T catenin gene to a quantitative trait locus on chromosome 10 in late-onset Alzheimer’s disease pedigrees. Hum Mol Genet 2003; 12: 3133-43.
82. Myers A, Wavrant De-Vrieze F, Holmans P et al. Full genome screen for Alzheimer disease: stage II analysis. Am J Med Genet 2002; 114: 235-44.
83. Sorbi S, Forleo P, Tedde A et al. Genetic risk factors in familial Alzheimer’s disease. Mech Ageing Dev 2001; 122:1951-60.